Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
10.93
Dollar change
+0.27
Percentage change
2.53
%
IndexRUT P/E- EPS (ttm)-1.33 Insider Own11.92% Shs Outstand50.10M Perf Week3.70%
Market Cap547.59M Forward P/E48.52 EPS next Y0.23 Insider Trans0.00% Shs Float44.13M Perf Month50.14%
Income-66.40M PEG- EPS next Q0.03 Inst Own113.17% Short Float / Ratio10.32% / 6.62 Perf Quarter-13.46%
Sales1.06B P/S0.52 EPS this Y-87.88% Inst Trans- Short Interest4.55M Perf Half Y-10.63%
Book/sh13.51 P/B0.81 EPS next Y22.31% ROA-4.32% Target Price10.25 Perf Year-23.62%
Cash/sh0.70 P/C15.56 EPS next 5Y- ROE-8.78% 52W Range7.12 - 16.64 Perf YTD-16.95%
Dividend- P/FCF12.56 EPS past 5Y- ROI-5.27% 52W High-34.31% Beta1.46
Dividend %- Quick Ratio1.52 Sales past 5Y-0.61% Gross Margin46.56% 52W Low53.51% ATR0.51
Employees11000 Current Ratio1.52 Sales Q/Q-2.79% Oper. Margin5.68% RSI (14)69.71 Volatility4.30% 6.04%
OptionableYes Debt/Eq0.91 EPS Q/Q-127.76% Profit Margin-6.26% Rel Volume0.66 Prev Close10.66
ShortableYes LT Debt/Eq0.86 EarningsNov 07 AMC Payout- Avg Volume687.69K Price10.93
Recom3.43 SMA2013.18% SMA5018.09% SMA200-9.25% Volume456,507 Change2.53%
Date Action Analyst Rating Change Price Target Change
Jun-20-23Initiated SVB Securities Underperform $10
Mar-16-23Initiated Goldman Neutral $15
Dec-13-22Initiated CJS Securities Market Perform $18
Dec-08-22Initiated UBS Sell $12
Dec-06-22Initiated Stifel Buy $17
Oct-14-22Initiated Oppenheimer Perform
Aug-30-22Initiated Jefferies Buy $20
Aug-25-22Initiated Credit Suisse Neutral $19
Aug-18-22Initiated Citigroup Neutral $17
Nov-12-23 08:57AM
Nov-09-23 01:24AM
Nov-07-23 07:15PM
06:10PM
04:11PM
10:00AM Loading…
Nov-02-23 10:00AM
Oct-31-23 10:01AM
Oct-25-23 06:30PM
Oct-05-23 10:00AM
Oct-04-23 04:41PM
Oct-03-23 05:47PM
Aug-23-23 04:51PM
Aug-14-23 09:00AM
Aug-12-23 09:27AM
Aug-11-23 12:12AM
06:40PM Loading…
Aug-09-23 06:40PM
05:36PM
04:30PM
Aug-08-23 07:50AM
Jul-27-23 11:00AM
Jul-20-23 08:33AM
Jun-21-23 08:00PM
Jun-13-23 09:00AM
Jun-01-23 04:10PM
May-10-23 11:58PM
May-09-23 06:34PM
04:10PM
Apr-26-23 08:00PM
11:35AM
Apr-20-23 07:00AM
08:58AM Loading…
Apr-19-23 08:58AM
Apr-13-23 08:00AM
Apr-04-23 01:19PM
Mar-30-23 08:46AM
Mar-27-23 08:56AM
Mar-02-23 07:51AM
Feb-23-23 07:00AM
Feb-16-23 06:29PM
Feb-14-23 07:03PM
Jan-24-23 07:00AM
Jan-19-23 11:06AM
Jan-11-23 05:15AM
Dec-27-22 10:00AM
Dec-12-22 04:20PM
Dec-07-22 08:05AM
Dec-01-22 09:07PM
Nov-29-22 10:00AM
Nov-26-22 08:04PM
Nov-14-22 02:00PM
Nov-10-22 06:47AM
Nov-08-22 05:25AM
Nov-03-22 02:00PM
Nov-01-22 05:40PM
Oct-27-22 07:23AM
Oct-05-22 08:30AM
Oct-03-22 04:20PM
Sep-23-22 07:45AM
Aug-23-22 08:30AM
Aug-01-22 04:20PM
Jul-07-22 08:00AM
Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bolton JeffreyDirectorMay 26Buy11.612,00023,22019,597May 31 08:17 PM
SHAW L EDWARD JRDirectorMay 22Buy11.9810,000119,80038,989May 23 05:50 PM
Langham Ronald Leroy JREVP Clinical Excel. & StrategyMay 18Buy11.9910,000119,90044,328May 22 09:48 AM
Hoeflinger ErinDirectorMay 18Buy11.822,10024,82215,697May 22 10:15 AM
Bolton JeffreyDirectorMay 17Buy11.802,00023,60017,597May 18 03:01 PM